Statistics on Liver Cancer
Here are the American Cancer Society's most recent estimates for primary liver and bile duct cancers in the United States for 2010:
- About 24,120 new cases of primary liver cancer and bile duct cancer
- About 18,910 deaths from these cancers
This cancer is more common in men than in women. An average man's lifetime risk of getting liver or bile duct cancer is about 1 in 94, while an average woman's risk is about 1 in 212.
Click here for American Cancer Society 2011 Estimated US Cancer Death diagram.
Click here for slide on Major Risk Factors for Primary Liver Cancer.
Click here for map of Regional Variations in Hepatocellular Carcinonma-Related Mortality in the US.
The Liver Tumor Program at Methodist Specialty and Transplant Hospital
Texas ranks second in the number of newly diagnosed liver cancer cases and has one of the highest mortality rates in the country. Majority of the cases are diagnosed at a late stage where patient treatment options are minimal and unfortunately have only months to live. Multidisciplinary liver tumor boards such as the Liver Tumor Consortium offered at Methodist Specialty and Transplant Hospital and now Metropolitan Methodist Hospital, are the ideal forum to discuss the current multiple therapies available and improve patient survival. This unique Consortium was created out of a need to provide organized support for liver cancer. The multidisciplinary team includes transplant surgeons, general surgeons with special interest in solid organ tumors, interventional radiologists and oncologists.
There are multiple therapies available ranging from surgery, interventional radiology and chemotherapy. Our Consortium panel of experts meets to discuss the management of individual patients and design the best therapy for that particular case. It has been demonstrated that the outcome (survival) of patients with liver tumors improves if their cases are managed by medical teams.
Only through early tumor detection and physician collaboration can we improve current patient death rate. Methodist Specialty and Transplant physicians can thoroughly evaluate and perform latest procedures and therapies for liver tumor patient: laparoscopic treatment, radiology treatment, the Nanoknife and liver transplantation.
Important Facts about the Texas Transplant Institute Liver Transplant Program at
Methodist Specialty and Transplant Hospital:
- The Liver Transplant Program consistently has the best 1-year patient survival rates
among all liver transplant centers in Texas. Click here for statistics.
- Our 1-year patient survival rates are ranked well above average nationally.
Click here for statistics.
- On a percentage basis more medically-urgent transplants are performed here than
at any other program in Texas (based on patient MELD scores).
- Only liver disease center in Central and South Texas to offer new and innovative
treatment for primary liver cancer patients when neither resective surgical procedures
nor transplantation are a viable option.
- Has performed more than 200 liver transplants since program began in 2001.
- Approved by the United Network for Organ Sharing (UNOS), Medicare and Medicaid.
- We provide care for primary and metastatic liver tumors with multiple
therapies:radiofrequency ablation, radioactive microspheres, chemoembolization,
chemotherapy, liver resection and transplantation.
Please go to the Texas Transplant Institute website for more information on our transplant programs: www.TexasTransplant.org.
For more information about our Liver Tumor Consortium or Liver Transplant Program: call the Texas Transplant Institute Liver Disease and Transplant Clinic at: 210-575-4837.